IBRX vs AMGN: Which Stock is Better?
Side-by-side comparison of Immunitybio Inc and Amgen Inc in 2026
IBRX
Immunitybio Inc
$8.20
AMGN
Amgen Inc
$350.16
Key Metrics Comparison
| Metric | IBRX | AMGN | Winner |
|---|---|---|---|
| Market Cap | $7.95B | $191.53B | AMGN |
| P/E Ratio | N/A | 24.93 | AMGN |
| EPS (TTM) | $N/A | $14.25 | AMGN |
| Revenue Growth | 4.1% | 0.1% | IBRX |
| Gross Margin | 99.3% | 70.8% | IBRX |
Analyze IBRX
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IBRX or AMGN a better investment?
Comparing IBRX and AMGN: Immunitybio Inc has a market cap of $7.95B while Amgen Inc has $191.53B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IBRX and AMGN?
IBRX (Immunitybio Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IBRX or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IBRX or AMGN?
IBRX has higher revenue growth at 4.1% vs 0.1% for AMGN.
Which company is more profitable: IBRX or AMGN?
Immunitybio Inc (IBRX) has higher gross margins at 99.3% compared to 70.8% for AMGN.
Which is the larger company: IBRX or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $191.53B compared to $7.95B for IBRX.
Should I buy IBRX or AMGN in 2026?
Both IBRX and AMGN have investment merit. IBRX trades at $8.20 while AMGN trades at $350.16. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IBRX and AMGN stock?
Key differences: Market Cap ($7.95B vs $191.53B), P/E Ratio (N/A vs 24.9x), Revenue Growth (4.1% vs 0.1%), Gross Margin (99.3% vs 70.8%).